Rosuvastatin-induced gynaecomastia

Clinical Endocrinology

Volumn 73, Issue 3, 2010, Pages 421-422

  Picolos, Michalis K ^a   Zeniou, Vicki ^a   Michalis, Andreou ^b  

^a Alithias Endocrinology Center   (Cyprus)

^b Evangelistria Medical Center   (Cyprus)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ATENOLOL; METFORMIN; MEVINOLIN; ROSUVASTATIN; TELMISARTAN; TESTOSTERONE;

AGED; CASE REPORT; DRUG INDUCED DISEASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ECHOMAMMOGRAPHY; GREECE; GYNECOMASTIA; HUMAN; HYPERLIPIDEMIA; LETTER; MALE; MAMMOGRAPHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL EXAMINATION; PRIORITY JOURNAL;

AGED; FLUOROBENZENES; GYNECOMASTIA; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; PYRIMIDINES; SULFONAMIDES;

EID: 77955754774     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2010.03802.x     Document Type: Letter

References (7)

1. Braunstein, G.D. (2007) Clinical practice. Gynecomastia. New England Journal of Medicine, 357, 1229 1237.
2. Oteri, A., Catania, M.A., Travaglini, R., et al. (2008) Gynecomastia possibly induced by rosuvastatin. Pharmacotherapy, 28, 549 551.
3. Ismail, A.A. Barth, J.H. (2001) Endocrinology of gynaecomastia. Annals of Clinical Biochemistry, 38 (Pt 6 596 607.
4. Hammons, K.B., Edwards, R.F. Rice, W.Y. (2006) Golf-inhibiting gynecomastia associated with atorvastatin therapy. Pharmacotherapy, 26, 1165 1168.
5. Hugues, F.C., Gourlot, C. Le Jeunne, C. (2000) Drug-induced gynecomastia. Annales de Medecine Interne (Paris), 151, 10 17.
6. Aerts, J., Karmochkine, M. Raguin, G. (1999) Gynecomastia due to pravastatin. Presse Medicale, 28, 787.
7. Naranjo, C.A., Busto, U., Sellers, E.M., et al. (1981) A method for estimating the probability of adverse drug reactions. Clinical Pharmacology and Therapeutics, 30, 239 245. (Pubitemid 12149145)